Neurogenic Bladder and Quality of Life in Patients With Stroke

Istanbul Physical Medicine Rehabilitation Training and Research Hospital71 enrolled

Overview

This study investigated effects of the neurogenic bladder on the quality of life in stroke survivors. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder.

Neurogenic bladder after stroke is a commonly encountered medical condition which slows down the recovery process and exacerbates the functional status of the patient. The neurogenic bladder may possibly affect the quality of life of patients with stroke. Objectives: The aim of this study is to investigate the relationship between the quality of life and the neurogenic bladder in Turkish stroke survivors. Methods: 71 patients with stroke were included in the study. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder. Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires were applied to both groups for clinical evaluations.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Stroke, Complication Neurogenic Bladder

Interventions

QuestionnairesBEHAVIORAL

Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires

Eligibility

Sex: ALLMin age: 30 YearsMax age: 88 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hemorrhagic or ischemic stroke * No previous stroke history * Disease duration \> 6 months Exclusion Criteria: * Patients with different stroke etiologies other than cerebrovascular events (such as traumatic and tumoral pathologies) * Previous multiple stroke history * Pre-stroke urinary complaints * Previous urogenital surgery history * Spinal Cord Injury (SCI) * Prostate volume of \> 35ml documented with urinary ultrasonography * Bladder outlet obstruction * Poorly controlled Diabetes Mellitus (DM) * Concomitant neurological diseases such as Multiple Sclerosis and Parkinson's Disease * Anticholinergic, alpha agonist-antagonist drug use * Sensory and global aphasia * Severe communication impairment

Locations (1)

Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Short Form-36 (SF-36)

Short Form-36 (SF-36) was used to evaluate the quality of life of the patients. The form consists of 36 items, which measure 8 dimensions. These include (1) Physical function, (2) Social function, (3) Pain, (4) Energy/vitality, (5) Role limitation due to emotional problems , (6) Role limitation due to physical health problems, (7) Mental health and (8) General perception of health. Each subscale is evaluated between 0-100 points. A higher score indicates the better health.

Time frame: 15 minutes

Secondary Outcomes

Beck Depression Inventory

Beck Depression Inventory was used to assess depressive signs. The scale consists of 21 items and the items are ordered from mild to severe. Evaluation is performed in a range of 0-63 points. The lower score indicates the better psychological profile.

Time frame: 15 minutes

Mini Mental Test (MMT)

Mini Mental Test (MMT) was used to evaluate the extent of cognitive impairment. MMT is divided into 5 main categories: orientation (10 points), memory (3 points), attention and calculation (5 points), recalling (3 points) and language (9 points). Total points is 30. Total score between 0-9 points is considered as severe cognitive impairment. Total score between 10-19 points is considered as moderate cognitive impairment. Total score between 20-23 points is considered as mild cognitive impairment. Total score between 24-30 points is considered as normal.

Time frame: 15 minutes

Brunnstrom scale

Brunnstrom scale is used to evaluate separately upper extremity, lower extremity or hand functions. Six stages are defined. Stage 1: No active movement, Stage 2: Mild spasticity, weak flexor-extensor synergy patterns, Stage 3: Marked spasticity, synergy patterns are evident, Stage 4: Some isolated movements other than synergy patterns can be seen, Stage 5: Decreased spasticity, most muscle activities are isolated, Stage 6: Phasic and well-coordinated isolated movements are performed. A higher point indicates the better status.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.